Consistency between cross-sectional and longitudinal SNP: Blood lipid associations

European Journal of Epidemiology

Volumn 27, Issue 2, 2012, Pages 131-138

  Costanza, Michael C ^a,b,c   Beer Borst, Sigrid ^d   James, Richard W ^a   Gaspoz, Jean Michel ^a   Morabia, Alfredo ^e,f  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF VERMONT   (United States)

^c Rushden   (United Kingdom)

^d BERN UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^e CITY UNIVERSITY OF NEW YORK   (United States)

^f City University of New York ^*  (United States)

Author keywords

Association; Blood cholesterol; Crosssectional design; Genetic marker; Longitudinal design; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; GENETIC ASSOCIATION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SWITZERLAND; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC MARKERS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; SWITZERLAND;

EID: 84860309307     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9670-1     Document Type: Article

References (18)

1. Bauerfeind A, Knoblauch H, Costanza MC, et al. Concordant association of lipid gene variation with a combined HDL/LDLcholesterol phenotype in two european populations. Hum Hered. 2006;61:123-31. (Pubitemid 44385441)
2. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161-9. (Pubitemid 351171403)
3. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009;41:47-55.
4. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009;41:56-65.
5. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-13.
6. Costanza MC, Cayanis E, Ross BM, et al. Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population. Am J Epidemiol. 2005;161:714-24.
7. Chasman DI, Posada D, Subrahmanyan L, et al. Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA. 2004;291:2821-7. (Pubitemid 38747801)
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
9. Knoblauch H, Bauerfeind A, Toliat MR, et al. Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum Mol Genet. 2004;13:993-1004. (Pubitemid 38702186)
10. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76-80.
11. Hegele RA, Connelly PW, Hanley AJ, et al. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. Arterioscler Thromb Vasc Biol. 1997;17:2753-8. (Pubitemid 28016018)
12. Russo GT, Meigs JB, Cupples LA, et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis. 2001;158:173-81. (Pubitemid 32735482)
13. Li WW, Dammerman MM, Smith JD, et al. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest. 1995;96:2601-5.
14. Olivieri O, Bassi A, Stranieri C, et al. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res. 2003;44:2374-81. (Pubitemid 38082496)
15. Morabia A, Cayanis E, Costanza MC, et al. Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors. Hum Mol Genet. 2003;12:2733-43. (Pubitemid 37407110)
16. Morabia A, Bernstein M, Kumanyika S, et al. Development and validation of a semi-quantitative food questionnaire based on a population survey [French]. Soz Praventivmed. 1994;39:345-69.
17. WHO (World Health Organization). Estimating levels and patterns of alcohol consumption from national surveys. In: International guide for monitoring alcohol consumption and related harm. WHO, Geneva; 2000. pp. 37-62.
18. SAS Institute Inc. (Copyright- 2008). SAS/STAT software, version 9.2 of the SAS System for Microsoft Windows.